Neonatal lupus: clinical features and management.

Area of Science:

• Pediatrics
• Rheumatology
• Immunology

Background:

• Neonatal lupus is an uncommon autoimmune disorder affecting infants, characterized by skin lesions and/or congenital heart block.
• Maternal autoantibodies, primarily Ro/La family, are present in nearly all cases, though only a small percentage of mothers with these antibodies have affected infants.
• The disease can manifest with cutaneous, cardiac, hepatobiliary, or hematologic issues, often involving only one or two organ systems.

Purpose of the Study:

• To summarize the clinical manifestations, diagnosis, pathogenesis, and management of neonatal lupus.
• To highlight the role of maternal autoantibodies in the disease's development.
• To discuss current therapeutic interventions and the long-term prognosis for affected children.

Main Methods:

• Review of existing literature on neonatal lupus, including clinical case studies and etiological research.
• Analysis of diagnostic criteria, emphasizing the importance of maternal autoantibody testing (Ro/La).
• Examination of therapeutic strategies, including corticosteroids, and their efficacy.

Main Results:

• Cutaneous lesions typically appear within weeks of birth, often on the face and scalp, resolving without scarring.
• Complete heart block is the most common cardiac manifestation, often developing in utero and generally irreversible.
• Hepatobiliary and hematologic abnormalities occur in about 10% of cases; mothers may be asymptomatic but can develop autoimmune disease later.

Conclusions:

• Neonatal lupus is strongly associated with maternal autoantibodies, implicating them in the disease's pathogenesis.
• Early intervention and treatment, primarily with corticosteroids, are key management strategies, though optimal therapy is still under investigation.
• Long-term outcomes are being studied, with some children developing other autoimmune diseases later in life.